SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-046031
Filing Date
2019-08-15
Accepted
2019-08-15 08:42:28
Documents
2
Period of Report
2019-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5649
2 EX-24 DOCUMENT attachment1.htm EX-24 3491
  Complete submission text file 0001209191-19-046031.txt   10618
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Issuer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address
Leavitt Chase C. (Reporting) CIK: 0001777467 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12830 | Film No.: 191028572